Incannex expands IHL-675A indications to include COPD, asthma, bronchitis, and other inflammatory lung conditions – after receiving positive results from additional in vivo studies Feb 4, 2021 ASX News Incannex Healthcare (ASX:IHL) Send Share Share
Incannex: Positive pre-IND meeting with US FDA Apr 22, 2021 | ASX News, Incannex Healthcare (ASX:IHL)
Purpose Designed Innovation Hub for HTG at Technology Park WA Feb 12, 2021 | ASX News, Harvest Technology Group (ASX:HTG)
